In response to the Brazilian Ministry of Health’s official declaration of the Zika virus as a public health emergency in November 2015, GloPID-R quickly assembled an Outbreak Committee in early December 2015 to assess the outbreak and launch research projects.
With three of GloPID-R’s 27 members based in Brazil (Instituto Fiocruz, Sao Paulo Research Foundation (FAPESP) and Instituto Butantan), GloPID-R reacted quickly. Instituto Fiocruz was instrumental in providing information on Zika’s effects on the population from a regional perspective and the research challenges the virus poses.
GloPID-R members coordinated to launch several research projects. GloPID-R then hosted a GloPID-R Zika Virus Research Workshop in Sao Paulo, Brazil on November 30 – December 2, 2016 to facilitate collaboration on these funded projects.
4 EU-funded Zika consortia, funded by GloPID-R members, teamed up to discuss a common strategy for a ZIKV vaccine development during the International Symposium held in Marseille, France in June 2018. The aim of this project is to produce a safe, effective, and affordable preventive vaccine by using a delivery platform technology based on a measles vector (MV).
Four Zika thematic working groups were formed to cover issues related to etiology, vaccines, diagnostics, and vector control. These groups published documents on their findings that are available in our resources section.